Novartis, Roche back French gene therapy start-up Vivet – WHTC
Endpoints News |
Novartis, Roche back French gene therapy start-up Vivet
WHTC (Reuters) – French gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with backing from the venture arms of Swiss drugmakers Novartis and Roche. Other investors … GenSight vet Combal grabs $40M from Novartis, Roche group for second-wave gene therapy biotech Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating … |
